NASDAQ
1.08USD
+0.02 (+1.89%)
We have scored 5 news catalysts on IceCure Medical Ltd (ICCM) over the past 12 months. The biggest single-day move next to one of them came Aug 24, 2026, when ICCM closed −6.6%: “IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands”. Coverage across the window leans positive (average ticker sentiment +0.20). Most of the impact sits in sector healthcare and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
2.4M
P/E
—
EPS
—
Beta
0.43
52W range
0.96-25.79
Day range
1.07–1.12
Open
1.09
Prev close
1.06
Volume
147K
Avg volume
3.4M
Dividend
0.00
IPO
2021-08-26
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about IceCure Medical Ltd — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for ICCM: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
